Abstract
The effects of hypotensive agents (captopril, enalaprilat, and lisinopril) on the activities of components of the fibrinolytic system (FS) and the effects of antifibrinolytic agents (6-aminohexanoic acid (6-AHA) and tranexamic acid (t-AMCHA)) on the activities of angiotensin converting enzyme (ACE) were studied in vitro. Enalaprilat did not affect the FS activity. Captopril considerably inhibited the amidase activities of urokinase (u-PA), tissue plasminogen activator (t-PA), and plasmin ([I]50 (2.0−2.6) ± 0.1 mM), and the activation of Glu-plasminogen by t-PA and u-PA ([I]50 (1.50−1.80) ± 0.06 mM), which may be due to the presence of a mercapto group in the inhibitor molecule. Lisinopril did not affect the amidase activities of FS enzymes, but stimulated Glu-plasminogen activation by u-PA and inhibited activation fibrin-bound Glu-plasminogen by t-PA ([I]50 (12.0 ± 0.5) mM). Presumably, these effects can be explained by the presence in lisinopril of a Lys side residue, whose binding to lysine-binding Glu-plasminogen centers resulted, on the one hand, in the transformation from its closed conformation to a semi-open one and, on the other hand, in its desorption from fibrin. Unspecific inhibition of the activity of ACE, a key enzyme of the renin-angiotensin system, in the presence of 6-AHA and t-AMCHA ([I]50 10.0 ± 0.5 and 7.5 ± 0.4 mM, respectively) was found. A decrease in the ACE activity along with the growth of the fibrin monomer concentration was revealed. The data demonstrate that, along with endogenous mediated interaction between FS and RAS, relations based on the direct interactions of exogenous inhibitors of one system affecting the activities of components of another system can take place.
Similar content being viewed by others
Abbreviations
- ACE:
-
angiotensin-converting enzyme
- 6-AHA, AFK-pNA:
-
INI-Ala-Phe-Lys p-nitroanilide; 6-aminohexanoic acid
- t-AMCHA:
-
trans-(4-aminomethyl)cyclohexanecarboxylic (or tranexamic) acid
- FS:
-
fibrinolytic system
- RAS:
-
renin-angiotensin system
- Glu-Pg:
-
native plasminogen Glu form
- LBS:
-
lysine-binding sites
- t-PA:
-
tissue plasminogen activator
- u-PA:
-
double-stranded urokinase
- PAI-1:
-
type 1 plasminogen activator inhibitor
References
Saksela, O. and Rifkin, D.B., Annu. Rev. Cell Biol., 1988, vol. 4, pp. 493–526.
Collen, D. and Lijnen, H.R., Blood, 1991, vol. 78, pp. 3114–3124.
Lijnen, H.R., Ann. N.Y. Acad. Sci., 2001, vol. 936, pp. 226–236.
Ghosh, S., Ellerbroek, S.M., Wu, Y., and Stack, M.S., Fibrinolysis, 2000, vol. 14, pp. 87–97.
Booth, N.A., Fibrinol. Proteol., 2000, vol. 14, pp. 206–213.
Huckle, W.R. and Earp, H.S., Prog. Growth Factor Res., 1994, vol. 5, pp. 177–194.
Escobar, E., Rodriguez-Reyna, T.S., Arrieta, O., and Sotelo, J., Curr. Vasc. Pharmacol., 2004, vol. 2, pp. 385–399.
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., and Egido, J., Int. J. Biochem. Cell Biol., 2003, vol. 35, pp. 881–900.
Mombouli, J.V., Illiano, S., Nagao, T., Scott-Burden, T., and Vanhautte, P.M., Circ. Res., 1992, vol. 8, pp. 137–144.
Brown, N.J., Agirbasli, M.A., Williams, G.H., Litchfield, W.R., and Vaughan, D.E., Hypertension, 1998, vol. 32, pp. 965–971.
Mogielnicki, A., Chabielska, E., Pawlak, R., Szemraj, J., and Buczko, W., Thromb. Haemost., 2005, vol. 93, pp. 1069–1076.
Brown, N.J., Gainer, J.V., Murphey, L.J., and Vaughan, D.E., Circulation, 2000, vol. 102, pp. 2190–2196.
Hasan, A.A., Amenta, S., and Schmaier, A.H., Circulation, 1996, vol. 94, pp. 517–528.
Pretorius, M., Rosenbaum, D.A., Vaughan, D.E., and Brown, N.J., Circulation, 2003, vol. 107, pp. 579–585.
Yusuf, S. and Lonn, E., Eur. Heart. J., 1998, vol. 19, Suppl. J, pp. J36–J44.
Oshima, S., Ogawa, H., Mizuno, Y., Yamashita, S., Noda, K., Saito, T., Sumida, H., Suefuji, H., Kaikita, K., Soejima, H., and Yasue, H., Am. Heart J., 1997, vol. 34, pp. 961–966.
Ferres, H., Drugs, 1987, vol. 33,Suppl. 3, pp. 33–50.
Entsiklopediya lekarstv (Drug Encyclopedia), Krylov, Yu.F., Ed., Moscow: RLS-2001, 2001.
Kost, O.A., Chesnokova, N.B., Makarov, P.V., Nikol’skaya, I.I., Kazanskaya, N.F., Beznos, O.B., and Binevskii, P.V., RF Patent 2 277 411, Byull. Izobret., 2006, No. 16.
Ponting, C.P., Marshall, J.M., and Cederholm-Williams, S.A., Blood Coagul. Fibrinolysis, 1992, vol. 3, pp. 605–614.
Marshall, J.M., Brown, A.J., and Pointing, C.P., Biochemistry, 1994, vol. 33, pp. 3599–3606.
Marcus, G., De Pascuale, J.L., and Wissler, F.C., J. Biol. Chem., 1978, vol. 253, pp. 727–732.
Wiman, B., Lijnen, H.R., and Collen, D., Biochim. Biophys. Acta, 1979, vol. 579, pp. 142–154.
Collen, D., Thromb. Haemost., 1999, vol. 82, pp. 259–270.
Markus, G., Fibrinolysis, 1996, vol. 10, pp. 75–85.
Urano, T., de Serrano, V.S., Chiber, B.A.K., and Castellino, F.J., J. Biol. Chem., 1987, vol. 262, pp. 15959–15964.
Thorsen, S. and Mullertz, S., Scand. J. Lab. Invest, 1974, vol. 34, pp. 167–176.
Urano, T., de Serrano, V.S., Chiber, B.A.K., and Castellino, F.J., Biochemistry, 1988, vol. 27, pp. 6522–6528.
Moalli, R., Saldeen, K., and Saldeen, T., J. Pharmacol. Exp. Ther., 1987, vol. 243, pp. 897–900.
Aisina, R., Mukhametova, L., Gershkovich, K., and Varfolomeyev, S.D., Biochim. Biophys. Acta, 2005, vol. 1725, pp. 370–376.
Kost, O.A., Bovin, N.V., Chemodanova, E.E., Nasonov, V.V., and Ort, T.A., J. Mol. Recog., 2000, vol. 13, pp. 360–369.
Lowry, U.K., Rosenbrough, N.J., Farr, A.L., and Bandall, K.L., J. Biol. Chem., 1951, vol. 193, pp. 265–271.
Laemmly, U.K., Nature, 1970, vol. 227, pp. 680–685.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.I. Mukhametova, D.A. Gulin, P.V. Binevski, R.B. Aisina, O.A. Kost, I.I. Nikolskaya, 2008, published in Bioorganicheskaya Khimiya, 2008, Vol. 34, No. 4, pp. 471–478.
Rights and permissions
About this article
Cite this article
Mukhametova, L.I., Gulin, D.A., Binevski, P.V. et al. The in vitro cross-effects of inhibitors of renin-angiotensin and fibrinolytic systems on the key enzymes of these systems. Russ J Bioorg Chem 34, 421–427 (2008). https://doi.org/10.1134/S1068162008040055
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162008040055